Category: Business of health

8/14/2017

Why you should be wary of ‘ovarian reserve testing’ events at fertility clinics

1 7/20/2017

Journalists and consumers need to immunize themselves against hype about unproven vaccines

7/19/2017

Stem cell ads: Promise much, deliver little

4 5/16/2017

Cashing in on emotions: How pharma profits from medicalizing the normal spectrum of feelings

1 5/11/2017

Why we should all be wary when PR machines promote phase 2 studies

4 4/3/2017

‘Fake breakthrough, fake news:’ One physician-researcher’s takeaway on news coverage of MS drug Ocrevus

2 3/16/2017

Strip mall stem cells

7 2/23/2017

MD Anderson Cancer Center’s IBM Watson project fails, and so did the journalism related to it

2/20/2017

‘Are YOUR lips attractive?’ Clickbait science fuels clickbait journalism

13 1/31/2017

One key detail you’re unlikely to see in news stories about mammography screening guidelines

Blog

Opinions on other issues in news, journals, PR, advertising, marketing

@HealthNewsRevu

Retweet on Twitter HealthNewsReview.org Retweeted

National Breast Cancer Coalition @NBCCStopBC·

A lot of interesting workshops are happening now at the #NBCCSummit! @garyschwitzer, the publisher of @HealthNewsRevu, is discussing new cancer research news. #BeBold

Reply on Twitter 1520768892888567810 Retweet on Twitter 15207688928885678101 Like on Twitter 15207688928885678103 Twitter 1520768892888567810

HealthNewsReview.org @HealthNewsRevu·

Take all the issues enmeshed in any cancer screening story and amplify it with the liquid biopsy issue. @AP's ⁦@CarlaKJohnson⁩. did a solid job here. https://apnews.com/article/science-business-health-hodgkin-lymphoma-oregon-ca899bb9c4c7f1859d4e9ce16a1cf78d

Reply on Twitter 1516522980385472513 Retweet on Twitter 1516522980385472513 Like on Twitter 15165229803854725134 Twitter 1516522980385472513